174 related articles for article (PubMed ID: 27433810)
1. Gastrointestinal Dysfunction and Neuropathologic Correlations in Parkinson Disease.
Mrabet S; Ben Ali N; Achouri A; Dabbeche R; Najjar T; Haouet S; Belal S
J Clin Gastroenterol; 2016 Oct; 50(9):e85-90. PubMed ID: 27433810
[TBL] [Abstract][Full Text] [Related]
2. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.
Cersosimo MG; Benarroch EE
Neurobiol Dis; 2012 Jun; 46(3):559-64. PubMed ID: 22048068
[TBL] [Abstract][Full Text] [Related]
3. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
[TBL] [Abstract][Full Text] [Related]
4. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.
Zhong CB; Chen QQ; Haikal C; Li W; Svanbergsson A; Diepenbroek M; Li JY
Neurosci Bull; 2017 Oct; 33(5):483-492. PubMed ID: 28924920
[TBL] [Abstract][Full Text] [Related]
6. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
[TBL] [Abstract][Full Text] [Related]
7. Enteric Pathologic Manifestations of Alpha-Synucleinopathies.
Punsoni M; Friedman JH; Resnick M; Donahue JE; Yang DF; Stopa EG
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):543-548. PubMed ID: 29189256
[TBL] [Abstract][Full Text] [Related]
8. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
Pellegrini C; Antonioli L; Colucci R; Ballabeni V; Barocelli E; Bernardini N; Blandizzi C; Fornai M
Parkinsonism Relat Disord; 2015 Dec; 21(12):1407-14. PubMed ID: 26499757
[TBL] [Abstract][Full Text] [Related]
9. The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K; Vanden Berghe P
Cell Tissue Res; 2018 Jul; 373(1):313-326. PubMed ID: 29936550
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.
Annerino DM; Arshad S; Taylor GM; Adler CH; Beach TG; Greene JG
Acta Neuropathol; 2012 Nov; 124(5):665-80. PubMed ID: 22941241
[TBL] [Abstract][Full Text] [Related]
11. Neural control of the gastrointestinal tract: implications for Parkinson disease.
Cersosimo MG; Benarroch EE
Mov Disord; 2008 Jun; 23(8):1065-75. PubMed ID: 18442139
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
Aldecoa I; Navarro-Otano J; Stefanova N; Sprenger FS; Seppi K; Poewe W; Cuatrecasas M; Valldeoriola F; Gelpi E; Tolosa E
Neurosci Lett; 2015 Aug; 602():145-9. PubMed ID: 26163460
[TBL] [Abstract][Full Text] [Related]
13. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
14. Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease.
West CL; Mao YK; Delungahawatta T; Amin JY; Farhin S; McQuade RM; Diwakarla S; Pustovit R; Stanisz AM; Bienenstock J; Barbut D; Zasloff M; Furness JB; Kunze WA
J Parkinsons Dis; 2020; 10(4):1477-1491. PubMed ID: 32925094
[TBL] [Abstract][Full Text] [Related]
15. Constipation: an emerging risk factor for Parkinson's disease?
Stirpe P; Hoffman M; Badiali D; Colosimo C
Eur J Neurol; 2016 Nov; 23(11):1606-1613. PubMed ID: 27444575
[TBL] [Abstract][Full Text] [Related]
16. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
[TBL] [Abstract][Full Text] [Related]
17. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease.
Yan F; Chen Y; Li M; Wang Y; Zhang W; Chen X; Ye Q
Medicine (Baltimore); 2018 Jul; 97(28):e11337. PubMed ID: 29995769
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys.
Li X; Yang W; Li X; Chen M; Liu C; Yu S
Neurosci Lett; 2018 Jan; 662():276-282. PubMed ID: 29107086
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.
Edwards LL; Quigley EM; Pfeiffer RF
Neurology; 1992 Apr; 42(4):726-32. PubMed ID: 1565224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
